Elicio Therapeutics, Inc.
USD3.95
-0.05 (-1.25%)
CEO
Robert T. Connelly
IPO Date
2021-02-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.99
Prev. Close
$4.00
Day Low
$3.93
Day High
$4.10
52W Low
$2.66
52W High
$16.00
Market Cap
$0.08B
Volume
0.19M
| -1.2 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -309.5% | -129.7% | 0.61 | 1.68 | -1.2 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -316.4% | -124.5% | 0.84 | 1.56 | -0.6 |
| 31 Dec 2021 | FY | 95.6% | -93.2% | -32.4% | -27.4% | 0.06 | 8.08 | -0.7 |
| 31 Dec 2020 | FY | 36.9% | -2781.5% | 88.6% | -169.2% | -0.94 | 0.38 | -0.6 |
| 31 Dec 2019 | FY | 23.6% | -2734.2% | 218.8% | -342.1% | -0.58 | 0.23 | -1.2 |
| 31 Dec 2018 | FY | 90.6% | -497.0% | -105.9% | -75.2% | 0.00 | 3.49 | -0.9 |
| 31 Dec 2013 | FY | 51.8% | 9.6% | 27.0% | 5.7% | 2.27 | 2.28 | 0.1 |
| 31 Dec 2012 | FY | 49.7% | 4.2% | 18.0% | 2.8% | 3.18 | 1.87 | 0.1 |
| -3.9 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -264.2% | -35.6% | 1.40 | 3.29 | -4.5 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -575.8% | -35.8% | 8.13 | 2.28 | -2.9 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -125.9% | -39.8% | 0.65 | 1.83 | -1.8 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | 123.8% | -49.7% | -2.30 | 1.80 | -1.1 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | 99.2% | -49.1% | -1.37 | 3.40 | -0.9 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 437.6% | -45.9% | -3.89 | 0.88 | -1.5 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -242.9% | -48.3% | 1.37 | 2.37 | -1.5 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -78.7% | -33.0% | 0.61 | 1.68 | -2.2 |